GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Infinium Pharmachem Ltd (NSE:INFINIUM) » Definitions » Beneish M-Score

Infinium Pharmachem (NSE:INFINIUM) Beneish M-Score : -0.55 (As of Apr. 18, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Infinium Pharmachem Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.55 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Infinium Pharmachem's Beneish M-Score or its related term are showing as below:

NSE:INFINIUM' s Beneish M-Score Range Over the Past 10 Years
Min: -2.68   Med: -1.98   Max: -0.55
Current: -0.55

During the past 5 years, the highest Beneish M-Score of Infinium Pharmachem was -0.55. The lowest was -2.68. And the median was -1.98.


Infinium Pharmachem Beneish M-Score Historical Data

The historical data trend for Infinium Pharmachem's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infinium Pharmachem Beneish M-Score Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
- - -2.68 -1.98 -0.55

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Beneish M-Score Get a 7-Day Free Trial - -1.98 - -0.55 -

Competitive Comparison of Infinium Pharmachem's Beneish M-Score

For the Chemicals subindustry, Infinium Pharmachem's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infinium Pharmachem's Beneish M-Score Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Infinium Pharmachem's Beneish M-Score falls into.


;
;

Infinium Pharmachem Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Infinium Pharmachem for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0657+0.528 * 1.2283+0.404 * 1.2504+0.892 * 1.1875+0.115 * 0.5576
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8792+4.679 * 0.284903-0.327 * 0.445
=-0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹217 Mil.
Revenue was ₹1,356 Mil.
Gross Profit was ₹325 Mil.
Total Current Assets was ₹650 Mil.
Total Assets was ₹855 Mil.
Property, Plant and Equipment(Net PPE) was ₹198 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹27 Mil.
Selling, General, & Admin. Expense(SGA) was ₹20 Mil.
Total Current Liabilities was ₹174 Mil.
Long-Term Debt & Capital Lease Obligation was ₹78 Mil.
Net Income was ₹113 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹-130 Mil.
Total Receivables was ₹172 Mil.
Revenue was ₹1,142 Mil.
Gross Profit was ₹337 Mil.
Total Current Assets was ₹513 Mil.
Total Assets was ₹706 Mil.
Property, Plant and Equipment(Net PPE) was ₹189 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹13 Mil.
Selling, General, & Admin. Expense(SGA) was ₹20 Mil.
Total Current Liabilities was ₹368 Mil.
Long-Term Debt & Capital Lease Obligation was ₹101 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(217.162 / 1356.392) / (171.61 / 1142.249)
=0.160103 / 0.150239
=1.0657

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(336.537 / 1142.249) / (325.353 / 1356.392)
=0.294627 / 0.239866
=1.2283

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (650.112 + 197.716) / 854.527) / (1 - (513.131 + 188.564) / 706.122)
=0.007839 / 0.006269
=1.2504

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1356.392 / 1142.249
=1.1875

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.388 / (13.388 + 188.564)) / (26.679 / (26.679 + 197.716))
=0.066293 / 0.118893
=0.5576

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20.364 / 1356.392) / (19.504 / 1142.249)
=0.015013 / 0.017075
=0.8792

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((78.063 + 174.135) / 854.527) / ((100.611 + 367.691) / 706.122)
=0.295132 / 0.663203
=0.445

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(113.022 - 0 - -130.435) / 854.527
=0.284903

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Infinium Pharmachem has a M-score of -0.55 signals that the company is likely to be a manipulator.


Infinium Pharmachem Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Infinium Pharmachem's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Infinium Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.

Infinium Pharmachem Headlines

No Headlines